TBCEL expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.42039713324493E-11 |
Normal-vs-Stage2 |
1.82680000015978E-07 |
Normal-vs-Stage3 |
1.88737914186277E-15 |
Normal-vs-Stage4 |
1.68742797512778E-12 |
Stage1-vs-Stage2 |
3.720800E-01 |
Stage1-vs-Stage3 |
2.716100E-03 |
Stage1-vs-Stage4 |
2.661100E-03 |
Stage2-vs-Stage3 |
3.015800E-01 |
Stage2-vs-Stage4 |
1.925630E-01 |
Stage3-vs-Stage4 |
7.068200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62547753035369E-12 |
Normal-vs-AfricanAmerican |
3.88969967346497E-11 |
Normal-vs-Asian |
8.865700E-02 |
Caucasian-vs-AfricanAmerican |
1.419220E-01 |
Caucasian-vs-Asian |
3.076600E-01 |
AfricanAmerican-vs-Asian |
1.379230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
4.35207425653061E-14 |
Normal-vs-Female |
1.62825308791525E-12 |
Male-vs-Female |
7.322800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.94959999999922E-05 |
Normal-vs-Age(41-60Yrs) |
4.97159979850892E-10 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
5.50430001577951E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.171400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.118800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.022300E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.538600E-03 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.092100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.139440E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.811600E-02 |
Normal-vs-Grade 2 |
2.82659995409773E-09 |
Normal-vs-Grade 3 |
1.62436730732907E-12 |
Normal-vs-Grade 4 |
1.77202696960421E-12 |
Grade 1-vs-Grade 2 |
2.695000E-01 |
Grade 1-vs-Grade 3 |
8.115300E-03 |
Grade 1-vs-Grade 4 |
6.775500E-03 |
Grade 2-vs-Grade 3 |
1.117680E-03 |
Grade 2-vs-Grade 4 |
5.381400E-03 |
Grade 3-vs-Grade 4 |
4.966000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.30070456814269E-11 |
Normal-vs-ccB subtype |
1.32980293443552E-11 |
ccA subtype-vs-ccB subtype |
2.893400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.07331937676736E-12 |
Normal-vs-N1 |
1.371100E-04 |
N0-vs-N1 |
6.081200E-01 |
|
|